We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+8.65%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$7.44B
AUM Growth
+$696M
Cap. Flow
+$295M
Cap. Flow %
3.96%
Top 10 Hldgs %
25.63%
Holding
169
New
15
Increased
63
Reduced
24
Closed
17

Top Buys

Rank Stock Value
1
ZYME icon
Zymeworks
ZYME
+$57.2M
2
NCNO icon
nCino
NCNO
+$41.7M
3
VECT
VectivBio Holding AG Ordinary Shares
VECT
+$35.5M
4
ARGX icon
argenx
ARGX
+$33.8M
5
SHLS icon
Shoals Technologies Group
SHLS
+$31.8M

Top Sells

Rank Stock Value
1
SRPT icon
Sarepta Therapeutics
SRPT
+$52M
2
VRSK icon
Verisk Analytics
VRSK
+$37.6M
3
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$26.1M
4
SNDX icon
Syndax Pharmaceuticals
SNDX
+$24.1M
5
OKTA icon
Okta
OKTA
+$23.8M

Sector Composition

Rank Sector Weight
1 Healthcare 35.75%
2 Technology 29.25%
3 Industrials 12.31%
4 Consumer Discretionary 7.52%
5 Communication Services 5.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRNX icon
151
Crinetics Pharmaceuticals
CRNX
$8.85B
– –
-241,140
Closed -$3.69M
FENC icon
152
Fennec Pharmaceuticals
FENC
$344M
– –
-1,040,000
Closed -$6.46M
KALA icon
153
KALA BIO
KALA
$13.6M
– –
-1,381
Closed -$23.3M
LW icon
154
Lamb Weston
LW
$7.36B
– –
-203,000
Closed -$15.7M
OKTA icon
155
Okta
OKTA
$24.4B
– –
-108,000
Closed -$23.8M
ONTF
156
DELISTED
ON24
ONTF
– –
-13,478
Closed -$654K
PAYC icon
157
Paycom
PAYC
$7.53B
– –
-2,500
Closed -$925K
SLDB icon
158
Solid Biosciences
SLDB
$836M
– –
-72,125
Closed -$5.98M
SRPT icon
159
Sarepta Therapeutics
SRPT
$1.64B
– –
-697,156
Closed -$52M
TTD icon
160
CALL
Trade Desk
TTD
$8.59B
– –
-15,000
Closed -$1.13M
ZBH icon
161
Zimmer Biomet
ZBH
$18.4B
– –
-20,827
Closed -$3.24M
OLK
162
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
– –
-101,000
Closed -$3.64M
DBTX
163
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
– –
-200,000
Closed -$2.27M
SGFY
164
DELISTED
Signify Health, Inc.
SGFY
– –
-357,360
Closed -$10.5M
XLRN
165
DELISTED
Acceleron Pharma
XLRN
– –
-142,900
Closed -$19.4M
CHMA
166
DELISTED
Chiasma, Inc. Common Stock
CHMA
– –
-3,000,326
Closed -$9.39M
3 4 5 6
7

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q2 2021 Portfolio in Review

As of Q2 2021, Eventide Asset Management held 169 positions worth $7.44B, up 10% from $6.75B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Eventide Asset Management deployed $295M of net new capital in Q2 2021, opening 15 new positions and adding to 63 existing holdings. Its largest new stake was nCino: 662,500 shares worth $39.7M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 40% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Verisk Analytics, an estimated $37.6M trimmed.

  • Eventide Asset Management's largest Q2 2021 buy was nCino: 662,500 shares worth $39.7M.
  • Eventide Asset Management added most to Zymeworks in Q2 2021, an estimated $57.2M increase.
  • Eventide Asset Management's biggest Q2 2021 reduction was Verisk Analytics, cutting an estimated $37.6M.
  • Eventide Asset Management fully exited Sarepta Therapeutics in Q2 2021, selling an estimated $52M.
  • Eventide Asset Management's ten largest holdings make up 26% of its $7.44B portfolio in Q2 2021.
  • Eventide Asset Management opened 15 new positions and closed 17 in Q2 2021.
  • Eventide Asset Management's portfolio value rose 10% quarter-over-quarter to $7.44B.

Based on Eventide Asset Management's 13F filing for Q2 2021, filed 16 Aug 2021.